Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Am Acad Dermatol. 2017 Nov 24;78(4):701–709.e1. doi: 10.1016/j.jaad.2017.11.033

Table 2.

Multivariable analysis for positive screen or biopsy of melanoma, non-melanoma skin cancer, and any skin cancer

Positive screen Positive biopsy
Relative Risk (95% CI) p-value Relative Risk (95% CI) p-value
Melanoma*
 Male Sex 1.35 (0.98–1.86) 0.06 Not selected
 Age (years) 1.02 (1.01–1.03) < 0.001 1.04 (1.03–1.05) < 0.001
 Personal history of melanoma 1.93 (1.27–2.92) < 0.01 Not selected
Non-melanoma skin cancer*
 Male sex 1.91 (1.77–2.08) < 0.001 1.47 (1.33–1.62) < 0.001
 Age (years) 1.04 (1.04–1.05) < 0.001 1.01 (1.01–1.02) < 0.001
 Personal history of any skin cancer 1.30 (1.20–1.41) < 0.001 1.36 (1.23–1.50) < 0.001
Any skin cancer*
 Male Sex 1.88 (1.74–2.03) < 0.001 1.60 (1.45–1.75) < 0.001
 Age (years) 1.04 (1.04–1.04) < 0.001 1.04 (1.03–1.04) < 0.001
 Personal history of any skin cancer 1.26(1.17–1.37) < 0.001 1.43 (1.30–1.58) < 0.001
*

Significant covariates remaining after multivariable stepwise regression. Stepwise models orginally included hypothesis driven covariates of age, sex, and personal history of skin cancer and melanoma, with stepwise p-value cut off <0.05